Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I/II Trial of CD4-IgG2 [PRO 542] in HIV-Infected Children.

Trial Profile

Phase I/II Trial of CD4-IgG2 [PRO 542] in HIV-Infected Children.

Phase of Trial: Phase I

Latest Information Update: 18 May 2012

At a glance

  • Drugs PRO 542 (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 10 May 2012 Planned number of patients changed from 24 to 12 and additional lead trial centre identified as reported by ClinicalTrials.gov.as reported by ClinicalTrials.gov.
    • 10 May 2012 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
    • 13 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top